• Icatibant in Viral Infections: Insights for Antiviral Resear

  2026-05-30

  The reference study examines the clinical use of icatibant, a bradykinin B2 receptor antagonist, in severe viral infections such as hantavirus (PUUV) and COVID-19. It highlights both the potential benefits and the underlying pathophysiological rationale for targeting the kinin-kallikrein system in these settings, while emphasizing the need for more systematic research to clarify efficacy and timing of intervention.

• Biotin-16-UTP: Protocols and QC for RNA Labeling Workflows

  2026-05-29

  Biotin-16-UTP enables precise incorporation of biotin-labeled uridine into RNA during in vitro transcription, facilitating efficient RNA detection and purification. It is intended strictly for research applications and should not be used in diagnostic or clinical workflows. Proper storage and handling are essential to maintain reagent quality and experimental reliability.

• Levofloxacin (SKU B1959): Reliable Solutions for Cell-Based

  2026-05-29

  This article explores how Levofloxacin (SKU B1959), a synthetic fluoroquinolone antibiotic, addresses common laboratory challenges in cell viability, proliferation, and cytotoxicity assays. Designed for biomedical researchers, it provides evidence-based protocol guidance, discusses workflow reproducibility, and compares vendor reliability for Levofloxacin sourcing.

• Strategic Apoptosis Detection: TUNEL Assays in Translational

  2026-05-28

  This thought-leadership article explores the intersection of mechanistic apoptosis research and translational strategy, highlighting the pivotal role of TUNEL assay-based DNA fragmentation detection. Drawing on recent evidence in spinal cord injury and angiogenesis, it offers actionable protocol guidance and positions the TUNEL Apoptosis Detection Kit (DAB) from APExBIO as a cornerstone for advanced programmed cell death research.

• Tofacitinib Citrate (CP-690550): Advanced Mechanistic Insigh

  2026-05-28

  Explore the precise mechanism and unique endothelial effects of Tofacitinib citrate (CP-690550 citrate), a selective JAK3 inhibitor, in immune regulation research. This article provides an in-depth analysis of cutting-edge findings and practical implications for experimental design.

• ABT-263 (Navitoclax): Enabling Precision Apoptosis Assays

  2026-05-27

  ABT-263 (Navitoclax) empowers researchers to selectively eliminate senescent and apoptosis-resistant cancer cells, advancing caspase-dependent apoptosis research. Its high affinity for Bcl-2 family proteins and proven efficacy in complex cancer models differentiate it as a gold standard for apoptosis assays and senolytic workflows.

• CKI 7 dihydrochloride: Reliable CK1 Inhibition for Cell Assa

  2026-05-27

  CKI 7 dihydrochloride (SKU B4936) is a highly selective Casein kinase 1 inhibitor widely used for dissecting signaling pathways in cancer biology, apoptosis, and circadian rhythm research. This article provides scenario-driven guidance for optimal use, including real-world protocol parameters and evidence-based product selection. Researchers can enhance assay reproducibility and interpretability by leveraging CKI 7 dihydrochloride’s validated performance.

• c-Myc Tag Peptide: Strategic Leverage for Translational Prec

  2026-05-26

  This thought-leadership article dissects the mechanistic and translational value of the c-Myc tag peptide, illuminating how its precision displacement capabilities unlock new experimental control for researchers pursuing transcription factor regulation and cancer biology. Building on contemporary autophagy research and the latest immunoassay innovations, this piece guides translational scientists in deploying the c-Myc tag peptide for rigorous, reproducible discovery.

• Apicidin Disrupts Oocyte Maturation via Meiotic and Epigenet

  2026-05-26

  This study reveals that Apicidin, a natural histone deacetylase inhibitor and emerging mycotoxin, impairs oocyte maturation by disrupting the meiotic apparatus and altering histone acetylation. These findings highlight critical mechanistic links between environmental mycotoxin exposure, epigenetic regulation, and reproductive toxicity, with implications for toxicology screening and epigenetics research.

• Anlotinib Hydrochloride Suppresses Angiogenesis via Multi-Ki

  2026-05-25

  This study demonstrates that Anlotinib hydrochloride, a multi-target tyrosine kinase inhibitor, robustly inhibits angiogenesis by targeting VEGFR2, PDGFRβ, and FGFR1. The findings highlight its superior efficacy over other anti-angiogenic agents, supporting its utility in cancer research.

• Decoding MCL-1 Dependency: A-1210477 in Cancer Apoptosis Res

  2026-05-25

  Explore how MCL-1 inhibitor A-1210477 enables precise analysis of apoptosis induction in cancer cells. This in-depth guide bridges foundational science and advanced research workflows for targeting MCL-1 in cancer biology.

• Phosbind Biotin (SKU F4001): Reliable Phosphorylation Detect

  2026-05-24

  This article addresses real laboratory challenges in Western Blot detection of phosphorylated proteins, focusing on the application of Phos binding reagent (Phosbind) Biotin (SKU F4001) from APExBIO. Integrating scenario-driven Q&A, it demonstrates how the dinuclear metal complex phosphate binding mechanism of Phosbind Biotin offers reproducible, cost-effective, and sequence-independent solutions for protein phosphorylation analysis in biomedical research.

• Puromycin Dihydrochloride: Precision Selection & Translation

  2026-05-23

  Puromycin dihydrochloride empowers researchers with unmatched versatility for stable cell line selection and dynamic analysis of translational control. Its potent, rapid action as an aminonucleoside antibiotic unlocks robust workflows from basic maintenance to advanced ribosome function studies—backed by APExBIO quality and evidence-based protocols.

• Breast Cancer’s MCL-1 Dependence: Anti-Apoptotic Function Un

  2026-05-22

  Recent evidence shows that breast cancer cells rely on MCL-1 primarily for its canonical anti-apoptotic role, rather than non-apoptotic functions. This finding clarifies the mechanism behind the efficacy of selective MCL-1 inhibitors and informs targeted therapy strategies.

• Ruthenium Red: Benchmark Ca2+ Transport Inhibitor in Cell Si

  2026-05-22

  Ruthenium Red is the gold-standard Ca2+ transport inhibitor, enabling high-precision dissection of calcium signaling and mechanotransduction, particularly in cytoskeleton-dependent autophagy. This guide translates breakthrough findings and advanced workflows into actionable protocols and troubleshooting strategies for researchers seeking robust, reproducible results.

16211 records 1/1081 page Next 12345 下5页 Last page